Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions
Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities.
The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape.
Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, posture validation, and secure workforce access. The acquisition marks the company's entry into the Zero Trust Workforce Access market and lays the foundation for its identity security division, Specops, to offer a unified approach that evaluates both the user and the device before access is granted. Through the strategic integration of its solutions — spanning external risk, identity, and device trust — Outpost24 is setting a new standard for cybersecurity. The company’s roadmap is focused on next-generation AI capabilities to catapult businesses forward, enabling them to prioritize the most critical threats and secure their assets.
The recent acquisition followed by today’s funding announcement mark the conclusion of a stellar year for Outpost24. Earlier this year, the company launched CyberFlex, a flexible, next-generation solution that integrates External Attack Surface Management and Penetration Testing as a Service (PTaaS) to help organizations efficiently manage and secure external-facing applications. Built on a pay-as-you-go credit model, CyberFlex embodies the shift toward consumable cybersecurity — giving customers the flexibility to dynamically allocate testing resources, scale coverage, and control costs as their security priorities evolve.
“This renewed investment from Vitruvian Partners is a powerful endorsement of our strategy and momentum. We are focused on advancing our AI capabilities to help security teams not just find, but also rapidly and efficiently remediate vulnerabilities. This funding enables us to expand our global reach and deliver even greater impact for our customers worldwide,” said Ido Erlichman, CEO of Outpost24.
“Since our original investment in Outpost24 in 2022, the company has achieved impressive growth while further strengthening its leadership position in the global cyber security arena,” added Jussi Wuoristo, Partner at Vitruvian Partners. “This additional investment reflects our continued conviction in Outpost24’s team, technology, and strategy, and we look forward to supporting its continued international expansion and product innovation.”
With over two decades of expertise, a strong European foundation, and thousands of customers worldwide, Outpost24 is expertly positioned to help organizations stay ahead of evolving cyber threats. By combining its leading Attack Surface Management platform with Specops’ specialized identity and password security, and the newly added strength of device identity and secure workforce access, Outpost24 delivers a truly comprehensive security picture that moves beyond conventional scanning methods. This empowers security teams to instantly identify, prioritize, and remediate the most critical risks, fundamentally strengthening resilience across both digital and human attack surfaces.
About Outpost24
Outpost24 is a leading global provider of cybersecurity solutions, encompassing two specialized divisions to deliver comprehensive exposure and access management. The company helps thousands of organizations worldwide proactively identify, manage, and reduce cyber risk across their entire digital and human attack surface. This is achieved through the combined expertise of Outpost24, the Attack Surface Management division focused on holistic Exposure Management, and Specops, the Identity and Access Management provider specializing in world-class Identity and Password Security solutions. Founded in 2001 and headquartered in Sweden, Outpost24 operates globally with 12 offices worldwide, including in the US, UK, France, Belgium, Spain and Israel. For more information, visit https://outpost24.com.
About Vitruvian Partners
Vitruvian Partners is a global growth-focused investment firm with nine offices in Europe, the US and Asia. Vitruvian focuses on dynamic situations characterized by rapid growth and change across industries. Vitruvian has over $20 billion of active funds which have backed many global market leaders and innovators in their sectors, including Just Eat, Arrive (fka EasyPark), Accountor, CRF Health, Skyscanner, Wise, CFC, Darktrace, Bitdefender, and others. For more information, visit www.vitruvianpartners.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251216917045/en/
Contacts
Media Contact
Tila Pacheco
Eskenzi PR
tila@eskenzipr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Nexo Announces Landmark Crypto Partnership with Tennis Australia for Australian Open and Summer of Tennis17.12.2025 10:00:00 EET | Press release
Nexo, the premier digital assets platform, has entered a landmark multi-year global partnership with Tennis Australia, becoming the Official Crypto Partner of the Australian Open and the Summer of Tennis, including the United Cup, Adelaide International, Brisbane International, and Hobart International. This agreement marks the first time a digital asset company has partnered with a Grand Slam tournament, affirming Nexo’s prestige, long-term vision, and leadership at the intersection of elite sport and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216497915/en/ Antoni Trenchev, Co-founder, Nexo, noted: “The Australian Open stands at the intersection of excellence and ambition – precisely where Nexo positions itself. Our partnership reflects a shared commitment to disciplined performance and long-term thinking. We are honored to join Tennis Australia in elevating the sport while showcasing the value of int
VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 09:00:00 EET | Press release
VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 08:00:00 EET | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 05:00:00 EET | Press release
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 04:00:00 EET | Press release
GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations. SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience. By mode
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom